Short Interest in GeoVax Labs, Inc. (NASDAQ:GOVXW) Declines By 72.7%

GeoVax Labs, Inc. (NASDAQ:GOVXW) was the target of a significant decrease in short interest in October. As of October 15th, there was short interest totalling 300 shares, a decrease of 72.7% from the September 30th total of 1,100 shares. Based on an average daily volume of 30,400 shares, the short-interest ratio is currently 0.0 days.

GeoVax Labs Trading Up 16.2 %

NASDAQ:GOVXW traded up $0.02 during mid-day trading on Friday, hitting $0.13. 36,457 shares of the company’s stock traded hands, compared to its average volume of 23,390. The company has a fifty day moving average of $0.22 and a 200 day moving average of $0.13. GeoVax Labs has a twelve month low of $0.02 and a twelve month high of $0.65.

About GeoVax Labs

GeoVax Labs, Inc, a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections, and solid tumor cancers.